LAS VEGAS - nvtip -- InfoWerks Awarded $190,000 Grant from NCPDP Foundation to Streamline REMS Process

InfoWerks, a leading provider of healthcare data management solutions, has been awarded a $190,000 grant from the NCPDP Foundation to lead a groundbreaking project aimed at streamlining data exchange for the FDA's Risk Evaluation and Mitigation Strategy (REMS) plan. The project will leverage the REMS transaction within the NCPDP SCRIPT standard to enhance patient safety and reduce administrative burdens by minimizing manual processing delays.

Jeff Deitch, Chief Executive Officer at InfoWerks, expressed his enthusiasm: "Receiving this grant from the NCPDP Foundation is incredibly exciting. It propels us toward our goal of enhancing patient safety by streamlining the REMS process. With this support, we can empower patients and pharmacists alike, ensuring timely access to accurate data and promoting informed medication management."

More on nvtip.com

• Beycome Closes $2.5M Seed Round Led by InsurTech Fund
• Tru by Hilton Columbia South Opens to Guests
• Christy Sports donates $56K in new gear to SOS Outreach to help kids hit the slopes
• "BigPirate" Sets Sail: A New Narrative-Driven Social Casino Adventure
• Phinge CEO Ranked #1 Globally by Crunchbase for the Last Week, Will Be in Las Vegas Jan. 4-9, the Week of CES to Discuss Netverse & IPO Coming in 2026

The project will focus on collaborating with a pharmacy, a pharmacy management system vendor and a REMS administrator. This initiative aims to simplify REMS program implementation for pharmacies, improve patient information and monitoring, and empower healthcare providers to guide patients through the adoption of innovative or complex new treatments.

Kelee Petzelt, an industry consultant managing the project's testing and development, added, "The grant from the NCPDP Foundation is a game-changer for our project. It's not just about simplifying the REMS process; it's about revolutionizing the role of pharmacists in patient care. With real-time adjudication and streamlined workflows, we can elevate pharmacists to key stakeholders in ensuring the safe use of high-risk medications."

The use of the NCPDP SCRIPT standard in this project will ensure data accuracy, consistency, and security, which is fundamental to patient safety when dealing with high-risk medications and emerging therapies. By integrating standards-based data exchange into healthcare workflows and clinical decision-making, InfoWerks anticipates significant improvements in patient care and emerging therapy management.

More on nvtip.com

• Women's Everyday Safety Is Changing - The Blue Luna Shows How
• Microgaming Unveils Red Papaya: A New Studio Delivering Cutting-Edge, Feature-Rich Slots
• 5-Star Duncan Injury Group Expands Personal Injury Representation to Arizona
• The End of "Influencer" Gambling: Bonusetu Analyzes Finland's Strict New Casino Marketing Laws
• AI-Driven Cybersecurity Leader Gains Industry Recognition, Secures $6M Institutional Investment, Builds Momentum Toward $16M Annual Run-Rate Revenue

This grant was made possible with support from the FDB Patient Safety Founder's Donor Fund, the GoodRx Access to Care Founder's Donor Fund, and the NCPDP Foundation General Grant Fund. The project aligns with three of the NCPDP Foundation's strategic initiatives: increasing patient access to care, expanding the role and value of pharmacists, and enhancing patient safety.

About InfoWerks

www.infowerks.com